Target-Specific Assay Kits (e.g., HER2, PD-1/SHP-2)
Oncology Research
Key Facts
About Navinci Diagnostics
Navinci Diagnostics is a private, Uppsala-based company commercializing its proprietary Naveni® in situ proximity ligation technology for the spatial proteomics research market. The company offers flexible and target-specific assay kits, as well as services, to enable researchers to visualize and quantify protein interactions and modifications directly in cultured cells and tissue samples. Operating in the diagnostics and oncology sectors, Navinci is positioned as a tools and services provider in the rapidly growing field of spatial biology, catering primarily to academic and biopharma research customers. Its technology aims to bridge a gap in functional proteomic analysis by providing molecular-level spatial information that traditional methods lack.
View full company profileTherapeutic Areas
Other Oncology Research Drugs
| Drug | Company | Phase |
|---|---|---|
| Biofabrication for Micro-tumors | Aurita Bioscience | Research-Use Only |
| Clear Dx® Platform | Clear Labs | Research-Use-Only |
| Inducible Cancer Models (Therillume) | Recombinetics | Pre-clinical |